18 July 2022
: Case report 
Trust the Process: Prolonged Babesia Parasitemia in an Elderly Man with Asplenia from the American Midwest
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Educational Purpose (only if useful for a systematic review or synthesis)
Marko Ivancich1DEF*, Larry Lutwick2ABD, F.N.U. Shweta3ABCDEFDOI: 10.12659/AJCR.936326
Am J Case Rep 2022; 23:e936326
Table 1. Laboratory values. Chronological order of relevant laboratory tests performed throughout the patient’s treatment course.
| Lab parameter | Range | Day 0 | Day +1 | Week +1 | Week +4 | Week +6 | Week +9 | Week +18 |
|---|---|---|---|---|---|---|---|---|
| White blood cell count | 3.4–9.6×10/L | 13.9 | 16.3 | 9.1 | 9.5 | 7.6 | 6.5 | 6.6 |
| Hemoglobin | 13.2–16.6 g/dL | 12.2 | 9.9 | 8.4 | 10.9 | 11 | 11.8 | 11.6 |
| Hematocrit | 38.3–48.6% | 33.8 | 27.7 | 25.4 | 34 | 33.5 | 36.3 | 34.4 |
| Total erythrocyte count | 4.35–5.65×10/L | 3.51 | 2.91 | 2.54 | 3.1 | 2.97 | 3.25 | 3.25 |
| Platelet count | 135–317×10/L | 94 | 99 | 109 | 135 | 107 | 138 | 143 |
| Serum creatinine | 0.74–1.35 mg/dL | 1.14 | 1.7 | 0.8 | 0.98 | 0.9 | 0.86 | 0.96 |
| Aspartate aminotransferase | 8–48 U/L | 264 | 270 | 46 | 51 | 36 | ||
| Alanine aminotransferase | 7–55 U/L | 67 | 67 | 50 | 43 | 34 | 28 | 19 |
| Alkaline phosphatase | 40–129 U/L | 92 | 67 | 91 | 90 | |||
| Bilirubin, total | ≤1.2 mg/dL | 2 | 1.4 | 0.9 | 0.5 | |||
| Bilirubin, direct | 0.0–0.3 mg/dL | 0.5 | 0.4 | <0.2 | ||||
| C-reactive protein | ≤8.0 mg/L | 67.4 | 126.9 | 9.8 | 4.5 | <3 | ||
| Day 0 – date of first presentation, * values outside normal range for performing laboratory. | ||||||||